Organogenesis (ORGO) - 2025 Q4 - Earnings Call Transcript
Organogenesis (NasdaqCM:ORGO) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsDave Francisco - CFOGary S. Gillheeney, Senior - President, CEO, and Chair of the BoardNone - Company RepresentativeOperatorWelcome, ladies and gentlemen, to the Fourth Quarter and Full Year 2025 Earnings Conference Call for Organogenesis Holdings, Inc At this time, all participants have been placed in listen-only mode. Please note that this conference call is being recorded and that the recording will be a ...